All Stories

  1. Long-term benefits for lower socioeconomic groups by improving bowel screening participation in South Australia: A modelling study
  2. “No Child or Adult Would Ever Probably Choose to Have 16 Teaspoons of Sugar”: A Preliminary Study of Parents’ Responses to Sugary Drink Warning Label Options
  3. Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosis
  4. Second Primary Cancers Following Cancer Among Adolescents and Young Adults in Queensland, Australia, 1982–2018
  5. Multi-jurisdictional Prostate Cancer Registry Linkage.
  6. Interval cancers as related to frequency of recall to assessment in the South Australian population-based breast screening program: An exploratory study
  7. Impact of relational continuity of primary care in aged care: a systematic review
  8. “You can’t just eat 16 teaspoons of sugar so why would you drink 16 teaspoons’ worth of sugar?”: a qualitative study of young adults’ reactions to sugary drink warning labels
  9. The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study
  10. Antibiotic exposure six months preceding systemic therapy was associated with lower cancer survival
  11. Body image and quality of life in women with breast cancer: Appreciating the body and its functionality
  12. Variations in utilisation of colorectal cancer services in South Australia indicated by MBS/PBS benefits: a benefit incidence analysis
  13. Changes in five‐year survival for people with acute leukaemia in South Australia, 1980–2016
  14. Warning labels and interpretive nutrition labels: Impact on substitution between sugar and artificially sweetened beverages, juice and water in a real-world selection task
  15. Challenges for ethics committees in biomedical research governance: Illustrations from China and Australia
  16. Factors involved in treatment decision making for women diagnosed with ductal carcinoma in situ: A qualitative study
  17. Associations between breast cancer screening participation and residential area sociodemographic features, geographic accessibility, and features of screening venue location in Greater Sydney, Australia
  18. Investigating the breast cancer screening–treatment–mortality pathway of women diagnosed with invasive breast cancer: Results from linked health data
  19. Prognostic Differences of RAS Mutations: Results from the South Australian Metastatic Colorectal Registry
  20. Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer Registry
  21. Cancer Profiles, Times to Treatment, and Survival for Adolescents and Young Adults: Comparisons with Children and Older Adults in New South Wales, Australia
  22. Residential Area Sociodemographic and Breast Cancer Screening Venue Location Built Environmental Features Associated with Women’s Use of Closest Venue in Greater Sydney, Australia
  23. The premature mortality to incidence ratio (PREMIER): a person-centred measure of cancer burden
  24. Sharing Government Health Data With the Private Sector: Community Attitudes Survey
  25. Cohort profile: indigenous human papillomavirus and oropharyngeal squamous cell carcinoma study - a prospective longitudinal cohort
  26. Carcinosarcomas of the Uterus: Prognostic Factors and Impact of Adjuvant Treatment
  27. Overdiagnosis of screen‐detected breast cancer
  28. Residential area and screening venue location features associated with spatial variation in breast cancer screening invitation response rates: an observational study in Greater Sydney, Australia
  29. Female breast cancer treatment and survival in South Australia: Results from linked health data
  30. Breast cancer treatment and survival differences in women in remote and socioeconomically disadvantaged areas, as demonstrated by linked data from New South Wales (NSW), Australia
  31. Female breast cancer in New South Wales, Australia, by country of birth: implications for health-service delivery
  32. Intentions to reduce sugar-sweetened beverage consumption: the importance of perceived susceptibility to health risks
  33. Measuring psychosocial outcomes of men living with prostate cancer: feasibility of regular assessment of patient‐reported outcomes
  34. Late mortality in people with cancer: a population‐based Australian study
  35. The Impact of Cancer on Early Childhood Development: A Linked Data Study
  36. A randomised online experimental study to compare responses to brief and extended surveys of health-related quality of life and psychosocial outcomes among women with breast cancer
  37. An In-Depth Exploration of Knowledge and Beliefs Associated with Soda and Diet Soda Consumption
  38. Sharing Government Health Data With the Private Sector: Community Attitudes Survey (Preprint)
  39. Young‐onset colorectal cancer is associated with a personal history of type 2 diabetes
  40. Optimal care pathways: A national policy to improve quality of cancer care and address inequalities in cancer outcomes
  41. Female breast cancer in New South Wales, Australia, by country of birth: implications for health-service delivery
  42. Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer
  43. Cancers of the corpus uteri treated in South Australian public hospitals: Trends in clinical management and survival across three decades
  44. Engagement of General Practice in an Australian Organised Bowel Cancer Screening Program: A Cross-Sectional Survey of Knowledge and Practice
  45. Nothing beats taste or convenience: a national survey of where and why people buy sugary drinks in Australia
  46. Prevalence of Oral Human Papillomavirus Infection Among Australian Indigenous Adults
  47. Monitoring TNM stage of female breast cancer and survival across the South Australian population, with national and international TNM benchmarking: A population-based cohort study
  48. Consumption of Sugar-Sweetened Beverages, Juice, Artificially-Sweetened Soda and Bottled Water: An Australian Population Study
  49. Overdiagnosis of cancer in Australia: the role of screening
  50. History of screening by BreastScreen New South Wales of women with invasive breast cancer
  51. Treatment and outcomes of metastatic colorectal cancer patients in public and private hospitals: Results from the South Australian Metastatic Colorectal Cancer Registry
  52. Effect of mammography screening and sociodemographic factors on stage of female breast cancer at diagnosis in New South Wales
  53. Differences in breast cancer treatment pathways for women participating in screening through BreastScreen New South Wales
  54. Breast Cancer Incidence and Survival Among Young Females in Queensland, Australia
  55. Estimating the lifetime risks of cancer: the best measure depends on your purpose
  56. A population-based study of soft tissue sarcoma incidence and survival in Australia: An analysis of 26,970 cases
  57. Optimizing the measurement of comorbidity for a South Australian colorectal cancer population using administrative data
  58. Cancer treatment and the risk of cancer death among Aboriginal and non-Aboriginal South Australians: analysis of a matched cohort study
  59. Mix Design and Mechanical Properties of Rubberized Cement Stabilized Soil (RCSS) Pavers
  60. Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival
  61. Pre-diagnostic colonoscopies reduce cancer mortality - results from linked population-based data in South Australia
  62. Patterns of comorbidities in women with breast cancer: a Canadian population-based study
  63. The burden of cancer on primary and secondary health care services before and after cancer diagnosis in New South Wales, Australia
  64. Disparities in breast screening, stage at diagnosis, cancer treatment and the subsequent risk of cancer death: a retrospective, matched cohort of aboriginal and non-aboriginal women with breast cancer
  65. The effects of comorbidity on colorectal cancer mortality in an Australian cancer population
  66. Differences in cancer incidence by age at diagnosis between Aboriginal and non-Aboriginal people for cancer types included in Australian national screening programs
  67. Are Australians ready for warning labels, marketing bans and sugary drink taxes? Two cross-sectional surveys measuring support for policy responses to sugar-sweetened beverages
  68. “ When we were young, it really was a treat; now sugar is just the norm every day ” — A qualitative study of parents’ and young adults’ perceptions and consumption of sugary drinks
  69. Metastasectomy and BRAF mutation: An analysis of survival outcome in metastatic colorectal cancer.
  70. Type 2 diabetes as a potential risk marker for early onset colorectal cancer.
  71. Accounting for Immigrant Status when Calculating Cancer Incidence Rates for Bangkok
  72. Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings
  73. Evaluation of an intervention to train health professionals working with Aboriginal and Torres Strait Islander people to provide smoking cessation advice
  74. Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum
  75. Sugar-sweetened beverage (SSB) consumption, correlates and interventions among Australian Aboriginal and Torres Strait Islander communities: a scoping review
  76. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry
  77. Who drinks sugar sweetened beverages and juice? An Australian population study of behaviour, awareness and attitudes
  78. Patterns of health service utilisation among the Australian population with cancer compared with the general population
  79. The Use of Travel Time to Measure Geographic Accessibility to Breast Screening Services in New South Wales, Australia Short Paper
  80. Breast Screen Service Characteristics as a Measure of Accessibility
  81. Aboriginal women have a higher risk of cervical abnormalities at screening; South Australia, 1993–2016
  82. Developing a comorbidity index for comparing cancer outcomes in Aboriginal and non-Aboriginal Australians
  83. Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival
  84. Has cancer survival improved for older people as for younger people? New South Wales, 1980–2012
  85. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern
  86. Keratinocyte cancers in South Australia: incidence, geographical variability and service trends
  87. Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention
  88. Changes in the prevalence of comorbidity in the Australian population with cancer, 2007–2014
  89. Australian Adolescents and Young Adults: Trends in Cancer Incidence, Mortality, and Survival Over Three Decades
  90. Do we know what to do with our nonagenarian and centenarian patients with metastatic colorectal cancer (mCRC)? Results from the South Australian mCRC registry
  91. Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012)
  92. Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study
  93. Diabetes and smoking as predictors of cancer in Indigenous adults from rural and remote communities of North Queensland - A 15-year follow up study
  94. Comorbidities contribute to the risk of cancer death among Aboriginal and non-Aboriginal South Australians: Analysis of a matched cohort study
  95. Outcomes for metastatic colorectal cancer (mCRC) based on microsatellite instability.
  96. The impact of primary tumour resection and sidedness in patients with synchronous metastatic colorectal cancer (mCRC): Findings from the South Australian Metastatic Colorectal Cancer Registry (SAMCRC).
  97. Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis
  98. Incidence of Comorbidities in Women with Breast Cancer Treated with Tamoxifen or an Aromatase Inhibitor: An Australian Population-Based Cohort Study
  99. Development of Indicators to Assess Quality of Care for Prostate Cancer
  100. Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity
  101. “Prostate cancer is far more hidden…”: Perceptions of stigma, social isolation and help-seeking among men with prostate cancer
  102. Barriers and facilitators for health professionals referring Aboriginal and Torres Strait Islander tobacco smokers to the Quitline
  103. Heart failure following blood cancer therapy in pediatric and adult populations
  104. Female breast cancer management and survival: The experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly
  105. Cancer epidemiology in the small nations of Pacific Islands
  106. Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity
  107. Human papillomavirus infection and intrauterine growth restriction: a data-linkage study
  108. Reply to ‘Comment on ‘Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study’’
  109. The value of local registry data for describing cervical cancer management and outcomes over three decades in Australia
  110. Cancer survival disparities worsening by socio-economic disadvantage over the last 3 decades in new South Wales, Australia
  111. Bevacizumab first line and impact on subsequent anti-EGFR activity
  112. Sugar-sweetened beverage consumption, correlates and interventions among Australian Aboriginal and Torres Strait Islander communities: a scoping review protocol
  113. Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity
  114. After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales
  115. Disparities in cancer stage at diagnosis and survival of Aboriginal and non-Aboriginal South Australians
  116. Does exclusion of cancers registered only from death-certificate information diminish socio-demographic disparities in recorded survival?
  117. Patient-Reported Outcomes After Radiation Therapy in Men With Prostate Cancer: A Systematic Review of Prognostic Tool Accuracy and Validity
  118. Bevacizumab and its impact on survival for patients receiving subsequent anti-EGFR therapy: Updated results from the SA metastatic CRC registry.
  119. The outcome of patients (pts) with metastatic colorectal cancer (mCRC) based on site of metastases (mets) and the impact of molecular markers and site of primary cancer on metastatic pattern.
  120. Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy
  121. Use of guideline‐recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia
  122. Findings in young adults at colonoscopy from a hospital service database audit
  123. Cancer survivorship monitoring systems for the collection of patient-reported outcomes: a systematic narrative review of international approaches
  125. Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study
  126. An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review
  127. Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model
  128. Variations in outcomes for Indigenous women with breast cancer in Australia: A systematic review
  129. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999–2011
  130. Time to clinical investigation for Indigenous and non-Indigenous Queensland women after a high grade abnormal Pap smear, 2000–2009
  131. Bevacizumab and its impact on survival for patients receiving subsequent anti-EGFR therapy: Results from the South Australian metastatic colorectal cancer registry.
  132. Nonagenarian patients with metastatic colorectal cancer: Results from the South Australian metastatic colorectal cancer registry.
  133. Patterns of care for synchronous rectal cancer with liver-only metastasis: Results from the South Australian registry of metastatic colorectal cancer.
  134. Administrative data provide vital research evidence for maximizing health-system performance and outcomes
  135. Pancreatectomy is underused in NSW regions with low institutional surgical volumes: a population data linkage study
  136. Cancer registration challenges in low- and middle-income countries-the case of the Pacific Islands
  137. History, development and future of cancer screening in Australia
  138. The impact of geographic unit of analysis on socioeconomic inequalities in cancer survival and distant summary stage – a population‐based study
  139. Cancer Data and Aboriginal Disparities (CanDAD)—developing an Advanced Cancer Data System for Aboriginal people in South Australia: a mixed methods research protocol
  140. High quality data are the key to understanding inequalities in cancer outcomes for Aboriginal and Torres Strait Islander Australians
  141. Heart failure following cancer treatment: characteristics, survival and mortality of a linked health data analysis
  142. Prevalence of Comorbidities and Health Status among Current Cancer and Cancer Survivors: An Australian Population-Based Study
  143. Brain metastasis in advanced colorectal cancer: Results from the South Australian metastatic colorectal cancer (SAmCRC) registry
  144. Breast cancer screening-opportunistic use of registry and linked screening data for local evaluation
  145. Prostate cancer outcomes for men who present with symptoms at diagnosis
  146. A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease
  147. Short-term outcomes after surgical resection for colorectal cancer in South Australia
  148. Characteristics of patients with haematological and breast cancer (1996–2009) who died of heart failure‐related causes after cancer therapy
  149. Validation of administrative hospital data for identifying incident pancreatic and periampullary cancer cases: a population-based study using linked cancer registry and administrative hospital data in New South Wales, Australia
  150. Colorectal cancer treatment and survival over three decades at four major public hospitals in South Australia: trends by age and in the elderly
  151. Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry
  152. The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000‐2011)
  153. Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000–2011
  154. Differences in impact of Aboriginal and Torres Strait Islander status on cancer stage and survival by level of socio-economic disadvantage and remoteness of residence—A population-based cohort study in Australia
  155. The utility of linked cancer registry and health administration data for describing system-wide outcomes and research: a BreastScreen example
  156. Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry
  157. Cancer Data and Aboriginal Disparities Project (CanDAD) - an overdue cancer control initiative
  158. Development of an International Prostate Cancer Outcomes Registry
  159. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry
  160. Socio-demographic disadvantage and distant summary stage of cancer at diagnosis—A population-based study in New South Wales
  161. Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset
  162. Recent advances of sonodynamic therapy in cancer treatment
  163. BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?
  164. Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study
  165. Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades
  166. 2163 BRAF testing in the community setting; are we testing enough given the importance of BRAF mutation and the clinical implications?
  167. Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry
  168. Death Analysis of a Cohort of Blood, Lymphatic Cancer and Breast Cancer Patients Who Have Developed Heart Failure Following Cancer Treatment
  169. Risk profile of breast cancer following atypical hyperplasia detected through organized screening
  170. Abstracts of poster presentations
  171. Survival impact of primary tumor resection in patients (pts) with unresectable metastatic colorectal cancer (mCRC): Findings from the South Australian Metastatic Colorectal Cancer Registry (SAMCRC).
  172. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects
  173. Breast Cancer Characteristics and Survival Differences between Maori, Pacific and other New Zealand Women Included in the Quality Audit Program of Breast Surgeons of Australia and New Zealand
  174. Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia over three Decades
  175. Translation from clinical trials to routine practice: How to demonstrate community benefit
  176. Performance Indices of Needle Biopsy Procedures for the Assessment of Screen Detected Abnormalities in Services Accredited by BreastScreen Australia
  177. Survival for patients with resectable lung metastatic colorectal cancer (mCRC).
  178. Changing roles of population-based cancer registries in Australia
  179. Rising incidence of early-onset colorectal cancer in Australia over two decades: Report and review
  180. A qualitative investigation of knowledge, beliefs and attitudes regarding sugar-sweetened beverages, including responses to potential regulatory measures aimed at curbing obesity
  181. Estimating over-diagnosis of breast cancer (Authors' Reply)
  182. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?
  183. Colorectal cancer screening and subsequent incidence of colorectal cancer: results from the 45 and Up Study
  184. Monitoring approval of new legislation banning smoking in children's playgrounds and public transport stops in South Australia: Table 1
  185. Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia
  186. What factors are predictive of surgical resection and survival from localised non-small cell lung cancer?
  187. Breast cancer survival in New Zealand women
  188. Realising opportunities for evidence-based cancer service delivery and research: linking cancer registry and administrative data in Australia
  189. Does Exact Primary Site Impact on Outcome for Metastatic Colorectal Cancer (Mcrc)?
  190. A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening
  191. Development and Validation of a Risk Score Predicting Risk of Colorectal Cancer
  192. Cardiotoxicity following Cancer Treatment: Linked Health Data Analysis
  193. Influence of Service Characteristics on High Priority Performance Indicators and Standards in the BreastScreen Australia Program
  194. Colorectal Cancer Survival: An Analysis of Patients With Metastatic Disease Synchronous and Metachronous With the Primary Tumor
  195. Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population-based data linkage
  196. Patterns of care and outcomes for young patients (age < 40) with metastatic colorectal cancer (mCRC): Findings from a population-based registry.
  197. Survival improvements associated with access to biologic agents: Results from the South Australian (SA) Metastatic Colorectal (mCRC) Registry.
  198. Survival outcomes for patients with metastatic colorectal cancer (mCRC) based on primary site, right (R) colon versus left (L) colon versus rectal (Rec) primary: Results from the South Australian Registry of mCRC.
  199. Influence of Mammographic Screening on Breast Cancer Incidence Trends in South Australia
  200. What Roles should Population-based Cancer Registries be Playing in the 21st Century? Reflections on the Asian Cancer Registry Forum, Bangkok, February 2014
  201. Trends in migrant mortality rates in Australia 1981–2007: a focus on the National Health Priority Areas other than cancer
  202. A systematic review of surgical biopsy for LCIS found at core needle biopsy – Do we have the answer yet?
  203. Cancer survival for Aboriginal and Torres Strait Islander Australians: a national study of survival rates and excess mortality
  204. Right (R) or left (L) primary site of colorectal cancer and outcomes for metastatic colorectal cancer (mCRC): Results from the south Australian registry of mCRC.
  205. Analysing risk factors for poorer breast cancer outcomes in residents of lower socioeconomic areas of Australia
  206. The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®
  207. Factors predictive of immediate breast reconstruction following mastectomy for invasive breast cancer in Australia
  208. Do breast cancer risk factors differ among those who do and do not undertake mammography screening?
  209. Can cancer registries show whether treatment is contributing to survival increases for melanoma of the skin at a population level?
  210. Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?
  211. Impact of hormone replacement therapy use on mammographic screening outcomes
  212. Factors Predictive of Treatment by Australian Breast Surgeons of Invasive Female Breast Cancer by Mastectomy rather than Breast Conserving Surgery
  213. Risk Factors for Poorer Breast Cancer Outcomes in Residents of Remote Areas of Australia
  214. A population-based study of metastatic colorectal cancer in individuals aged ≥80 years
  215. Estimating prevalence of distant metastatic breast cancer: a means of filling a data gap
  216. Age effects on survival from early breast cancer in clinical settings in Australia
  217. Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis
  218. Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer
  219. Adherence to Recommended Treatments for Early Invasive Breast Cancer: Decisions of Women Attending Surgeons in the Breast Cancer Audit of Australia and New Zealand
  220. Survival From Synchronous Bilateral Breast Cancer: The Experience of Surgeons Participating in the Breast Audit of the Society of Breast Surgeons of Australia and New Zealand
  221. Trends in cancer mortality rates among migrants in Australia: 1981–2007
  222. A review of community engagement in cancer control studies among Indigenous people of Australia, New Zealand, Canada and the USA
  223. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study
  224. Breast Screening and Breast Cancer Survival in Aboriginal and Torres Strait Islander Women of Australia
  225. Survival from breast cancer: an analysis of Australian data by surgeon case load, treatment centre location, and health insurance status
  226. What factors affect the odds of NSW cancer patients presenting with localised as opposed to more advanced cancer?
  227. Estimating cancer incidence in Indigenous Australians
  228. Small Cell Lung Cancer: Patterns of care and their influence on survival - 25 years experience of a single Australian oncology unit
  229. An analysis of the effect of stage at diagnosis of bowel cancer on survival: Findings from the South Australian Clinical Registry (SACR) for metastatic colorectal cancer (mCRC).
  230. Impact of watching prior to commencement of chemotherapy for metastatic colorectal cancer (mCRC): Findings from the South Australian Clinical Registry (SACR) for mCRC.
  231. Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort
  232. A population-based study of metastatic colorectal cancer (mCRC) in people age 80 and older: Findings from the South Australian Clinical Registry (SACR) for mCRC.
  233. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment? - Yes
  234. Outcomes of lymphoma in South Australia, 1977-2007
  235. South Australian clinical registry for metastatic colorectal cancer
  236. Survival from breast cancers managed by surgeons participating in the National Breast Cancer Audit of the Royal Australasian College of Surgeons
  237. Variation in the management of early breast cancer in rural and metropolitan centres: Implications for the organisation of rural cancer services
  238. Epidemiology of neuroendocrine cancers in an Australian population
  239. Review Paper: The Health Status of Migrants in Australia: A Review
  244. Patterns of Surgical Treatment for Women with Breast Cancer in Relation to Age
  245. Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort
  246. Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?
  247. Variations in care for operable breast cancer and outcomes between rural and metropolitan centers in Australia
  248. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control
  249. Reasons for Improved Survival From Ovarian Cancer in New South Wales, Australia, Between 1980 and 2003
  250. Patient and carer perceptions of cancer care in South Australia
  251. Management and Survival Trends in Advanced Colorectal Cancer
  252. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care
  254. Survival and degree of spread for female breast cancers in New South Wales from 1980 to 2003: implications for cancer control
  256. A case–control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women
  257. Prognosis of sub-types of cancer of unknown primary (CUP) compared to metastatic cancer
  258. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia
  259. Benchmarking epidemiological characteristics of cervical cancer in advance of change in screening practice and commencement of vaccination
  260. Treatment and survival from breast cancer: the experience of patients at South Australian teaching hospitals between 1977 and 2003
  261. Endometrial cells as a predictor of uterine cancer
  262. A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program
  263. Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer
  264. Tobacco and alcohol-related mortality in men: estimates from the Australian cohort of petroleum industry workers
  265. Survival trends for advanced colorectal cancer (CRC): Are improvements only for patients in clinical trials?
  266. Prognostic importance of palpability as a feature of screen-detected breast cancers
  267. Factors predictive of preferred place of death in the general population of South Australia
  268. Update of mortality and cancer incidence in the Australian petroleum industry cohort
  269. Asbestos-Related Cancers in Refinery Workers in the Australian Petroleum Industry
  270. Treatment and Survival from Colorectal Cancer: The Experience of Patients at South Australian Teaching Hospitals Between 1980 and 2002
  271. Multiple primary cancers of separate organ sites: implications for research and cancer control (Australia)
  272. Does emotional support influence survival? Findings from a longitudinal study of patients with advanced cancer
  273. Female breast cancers are getting smaller, but socio-demographic differences remain
  274. Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer
  275. Time trends in lung cancer incidence by histology in South Australia: likely causes and public health implications
  276. A critical analysis of reasons for improved survival from invasive cutaneous melanoma
  277. Effects of variations in hysterectomy status on population coverage by cervical screening
  278. Risk of cancer in patients with scleroderma: a population based cohort study
  279. Use of radiotherapy in the primary treatment of cancer in South Australia
  280. Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival
  281. The epidemiology of gastric cancer
  282. Issues of consent and privacy affecting the functioning of ASERNIP-S
  283. The coverage of cancer patients by designated palliative services: a population-based study, South Australia, 1999
  284. Tumour location and prognostic characteristics as determinants of survival of women with invasive breast cancer: South Australian hospital-based cancer registries, 1987–1998
  285. An analysis of factors associated with interval as opposed to screen-detected breast cancers, including hormone therapy and mammographic density
  287. Lip cancer in South Australia, 1977–1996
  288. Somatic mutations, acetylator status, and prognosis in colorectal cancer
  289. Rehospitalisation for asthma within 12 months: unequal rates on the basis of gender at two hospitals
  290. Trends in perinatal characteristics in South Australia, 1981 to 1994, by place of residence of mother
  291. Near-fatal asthma in South Australia:descriptive features and medication use
  292. Perinatal mortality trends among South Australian Aboriginal births 1981–92
  293. Characteristics of near-fatal asthma in childhood
  294. Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.
  295. Trends in prostate cancer incidence and mortality rates in South Australia, 1977‐1993
  296. Brain cancer incidence, mortality and case survival: Observations from two australian cancer registries
  297. Near fatal asthma attacks: the reliability of descriptive information collected from close acquaintances.
  298. Evaluation of the lead Decontamination programme in the leading smelting town of port Pirie (South Australia)
  299. Trends in the terminal care of cancer patients: South Australia, 1981-1990
  300. Birthweight‐Specific Trends in Perinatal Mortality by Hospital Category in South Australia, 1985–1990
  301. Breech Presentation in South Australia, 1987–1989
  302. The association of low socio-economic status in metropolitan adelaide with maternal demographic and obstetric characteristics and pregnancy outcome
  303. Factors Predictive of Corneal Graft Survival
  304. The Association of Maternal and Socioeconomic Characteristics in Metropolitan Adelaide with Medical, Obstetric and Labour Complications and Pregnancy Outcomes
  305. The South Australian Cancer Registry: a means of assessing cancer incidence, mortality and case survival
  306. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA
  307. Radon daughter exposures at the Radium Hill uranium mine and lung cancer rates among former workers, 1952?87
  308. Case‐survival rates for infiltrating ductal carcinomas by category of hospital at diagnosis in South Australia
  309. Epidemiological characteristics of Legionella infection in South Australia: implications for disease control
  310. Malignant astrocytoma in South Australia: treatment and case survival
  311. Pregnancy and perinatal factors associated with persistently low apgar scores: An analysis of the birth records of infants born in South Australia
  312. Actuarial predictions from population‐based disease registries with unidentified random losses
  313. Infiltrating ductal carcinoma of the breast in South Australia
  314. Epidemiological features of melanoma in South Australia: implications for cancer control (for editorial comment, see page 490)
  315. Pregnancy and birth risk factors for intellectual disability in South Australia
  316. Cervical Cancer in South Australia: Trends in Incidence, Mortality and Case Survival
  317. The use of State and hospital‐based cancer‐registry data to describe the epidemiological and clinical characteristics of laryngeal cancer in South Australia
  318. Cancer case‐survival rates for South Australia: a comparison with US rates and a preliminary investigation of time trends
  319. Obstetric Profiles of Immigrant Women from Non-English Speaking Countries in South Australia, 1981–1983
  320. Professionally defined dental treatment needs of middle-aged and older patients attending 21 general practitioners, as related to tooth retention
  321. Determinants of the microbiological characteristics of spa pools in South Australia
  322. The dental health and treatment needs of middle-aged and older patients attending 21 general dental practitioners in South Australia
  323. Children's Blood Lead Levels in the Lead Smelting Town of Port Pirie, South Australia
  324. Melanoma case survival rates in South Australia by histological type, thickness and level of tumour at diagnosis
  325. Blood lead levels in children in the north‐west of Adelaide
  326. A Nine Year Retrospective Mortality Study of Workers in a British Pharmaceutical Company
  327. Increased tolerance to complete dentures after surgical modification of mylohyoid ridges
  328. Mortality from influenza and allied infections in South Australia during 1968‐1981
  329. Promotion of breast self‐examination in South Australia: A short‐term evaluation
  330. Determinants of case survival for cancers of the lung, colon, breast and cervix in South Australia
  331. Epidemiological surveillance of occupational health in Australia
  332. The association of naegleria fowleri with the chemical, microbiological and physical characteristics of South Australian water supplies
  333. Oral cancer in South Australia-incidence and case survival
  334. A Comparison of Australian Suicide Rates in 1969–73 and 1976–80
  335. Infiltrating ductal carcinoma of the breast in South Australia Sizes of primary lesions and histological evidence of axillary nodal metastases
  336. Byssinosis: A Cross-Sectional Study in an Australian Textile Factory
  337. Population‐based comparative study of campylobacter and salmonella enteritis in South Australia
  338. Survival of South Australian cancer patients
  339. Fluoridation II: An interim economic analysis
  340. The dental health status of children not included by parents in the South Australian School Dental Programme. A pilot study
  342. Fluoridation 1. Effects on children's caries rates and professionally defined requirements for dental care
  343. Assessing the effectiveness of dental health education in the South Australian School Dental Programme
  344. Saliva-based colorimetric test as an index of gingival inflammation in epidemiologic studies
  347. The effect of a pilot dental health education programme on high school students
  348. The sealing of fissures in a school dental programme
  349. The effect of treatment provided by dentists and therapists in the South Australian school dental service. The second report
  350. Tooth loss in South Australia
  351. The treatment of first permanent molars in a school dental programme: Implications for fissure sealants
  352. Tooth loss, the wearing of dentures and the demand for dental care in the south-east of South Australia
  353. Diagnosis, treatment planning and referral by school dental therapists
  354. The effect of treatment provided by dentists and therapists in the South Australian School Dental Service
  355. The association between dental caries and the availability of sweets in South Australian school canteens
  357. The dental health of South Australian country children
  358. The dental health and habits of South Australian children from different socio-economic environments
  359. The South Australian school canteen programme: An interim report
  360. A study of dental knowledge and behaviour in 1,000 Australian schoolchildren